New York, NY -- (ReleaseWire) -- 05/03/2013 --Itonis Inc. (Pink:ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, announced that the Company's manufacturer (Oasis Health Products, Inc.) has agreed to manufacture nasal spray, oral spray and nasal swab delivery form products for the relief and treatment of nausea for Itonis, Inc. exclusively.
Dr. Hensley commented, "We are pleased that we were able to secure Oasis' exclusivity. Oasis is a major domestic contract manufacturer. The exclusivity should avoid any potential of competitors seeking inroads with the use of a common manufacturer facility."
ITonis, Inc., a development stage company, through its subsidiary, Performance Mortgage Group, Inc., focuses on the provision of consumer financial services in the United States.
Find out what else is to know when trading ITNS by getting the complete trend analysis report here: http://stockreportdaily.com/market-scan/?symbol=ITNS
Federal National Mortgage Association (OTCQB: FNMA) trading at $ 0.83 in the current session, which is +0.011 (1.33%). The stock has a Range of 0.82 - 0.84. The stock has a 52 week low and high of 0.20 - 1.47 respectively. The stock has a Market Cap of 1.42B. The stock traded a volume of 4.58M. The stock has a 30 day average volume of 29.46M.
Statement by Jeffery Hayward, Senior Vice President and Head of Multifamily, on Release of Multifamily Market Analysis states "In 2012, we were asked by the Federal Housing Finance Agency (FHFA) to analyze the potential effects of discontinuing the government guarantee of Fannie Mae's Multifamily business and creating a new, private multifamily company. We conducted a careful, measured analysis that flowed solely from the assumptions and questions that we were provided by FHFA.”
He added, “Our analysis found that, without a government guarantee, a successor to our current model would not be able to provide the same level of liquidity to the market throughout market cycles, and likely would not serve many of the markets we have historically served.”
Get the latest trend analysis reports on FNMA here:
Stockreportdaily.com issues momentum alerts on stocks that can provide gains to day traders. Stockreportdaily.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. Stockreportdaily.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Stockreportdaily.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the Stockreportdaily.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Stockreportdaily.com
Stockreportdaily.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Stockreportdaily.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
For full disclaimer visit; http://www.Stockreportdaily.com/disclaimer/
Stock Report Daily